The list of rejected Article 13.1 claims published today alongside the permitted list in the Union Register of the European Commission is premature in light of the controversy surrounding the criteria used for their assessment, the European Federation of Associations of Health Product Manufacturers (EHPM) has said.

Industry innovation in light of EU regulatory developments is the focus of next week’s Vitafoods Europe Discussion Forum in Geneva where senior regulatory and marketing experts will discuss the key areas of opportunity and concern.

He’s no Billy Crystal, but Integrated Marketing Group’s Jeff Hilton will host the annual Nutraceutical Business & Technology (NBT) Awards on May 23 at The Starling Geneva Hotel and Conference Center in Geneva, Switzerland.

Carbery Group had a positive year in 2011 with revenues increasing by 14.5% to 256.5 million Euros and profit before tax (PBT) increasing by 27.8% to 8.7 million Euros.    

Julian Price joins world’s pre-eminent competitive intelligence and market analysis consultancy.    

New Findings of Daily Consumption of Soy Isoflavones and Cacao-Flavonoids in Diabetes Type 2 Patients

Dutch Medical Brands receives first European Class IIa Medical Device Status

As the controversy surrounding genetically modified crops continues to gather pace, the future of Europe's non-GM supply remains uncertain. However, one UK company offering food manufacturers non-GM assurances is leading clean label ingredients specialists, Ulrick & Short Ltd, which has recently extended its crop range to now include non-GM rice and waxy rice. An extension of the company's Synergie range of functional flours and starches, the addition of rice ingredients will offer manufacturers a non-GM and allergen free starch solution, whilst delivering even more texture capabilities.